// App-Quantinova.ai

: Factor VIII Pharmacokinetics Associate with VWF Clearance, VWF‐FVIII Binding Activity, and Variants in the CLEC4M Gene in an Adult Hemophilia A Population

Researchers

Presenter

  • L.L. Swystun

Principal Investigators

  • K. Ogiwara

  • A.S. Paine

  • S. Kepa

  • S.J. Choi

  • W. Hopman

  • J. Rejtoe

  • I. Pabinger

  • D. Lillicrap

Medical Centers

  • Queen's University, Department of Pathology and Molecular Medicine, Kingston, ON, Canada

  • Medical University of Vienna, Division of Hematology and Hemostasis, Department of Medicine 1, Vienna, Austria

  • Queen's University, Public Health Sciences, Kingston, ON, Canada

Locations

  • Canada

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • rFVIII

  • FVIII

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved